Genetic analyses for FCD type II and HME have focused on the PI3K-AKT3-mTOR pathway after identifying somatic variants of MTOR, PIK3CA, and AKT3 as the gene aberrations [17, 18, 24]. Here, MTOR is linked to isolated focal cortical dysplasia type II.